User profiles for Garry G. Graham

Graham Garry

Professor of Pharmacology, University of New South Wales
Verified email at unsw.edu.au
Cited by 11114

Clinical pharmacokinetics of metformin

GG Graham, J Punt, M Arora, RO Day… - Clinical …, 2011 - Springer
Metformin is widely used for the treatment of type 2 diabetes mellitus. It is a biguanide
developed from galegine, a guanidine derivative found in Galega officinalis (French lilac). …

Clearance concepts in pharmacokinetics

M Rowland, LZ Benet, GG Graham - Journal of pharmacokinetics and …, 1973 - Springer
The kinetics of a drug eliminated by first-order processes in a perfusion-limited isolated perfused
organ system are examined. In this model, the mean clearance, determined by dividing …

Mechanism of action of paracetamol

GG Graham, KF Scott - American journal of therapeutics, 2005 - journals.lww.com
Paracetamol (acetaminophen) is generally considered to be a weak inhibitor of the synthesis
of prostaglandins (PGs). However, the in vivo effects of paracetamol are similar to those of …

The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings

GG Graham, MJ Davies, RO Day, A Mohamudally… - …, 2013 - Springer
Paracetamol is used worldwide for its analgesic and antipyretic actions. It has a spectrum of
action similar to that of NSAIDs and resembles particularly the COX-2 selective inhibitors. …

A benefit-risk assessment of benzbromarone in the treatment of gout: was its withdrawal from the market in the best interest of patients?

MHH Lee, GG Graham, KM Williams, RO Day - Drug safety, 2008 - Springer
Benzbromarone, a potent uricosuric drug, was introduced in the 1970s and was viewed as
having few associated serious adverse reactions. It was registered in about 20 countries …

Non-steroidal anti-inflammatory drugs (NSAIDs)

RO Day, GG Graham - Bmj, 2013 - bmj.com
… Richard O Day professor of clinical pharmacology1 2, Garry G Graham professorial
visiting fellow1 2 … Her present drug treatment is paracetamol (4 g daily) and metformin. …

Antibacterial actions of secreted phospholipases A2. Review

TJ Nevalainen, GG Graham, KF Scott - … (BBA)-Molecular and Cell Biology of …, 2008 - Elsevier
Antibacterial properties of secreted phospholipases A 2 (PLA 2 ) have emerged gradually.
Group (G) IIA PLA 2 is the most potent among mammalian secreted (s) PLA 2 s against Gram-…

Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol

RO Day, GG Graham, M Hicks, AJ McLachlan… - Clinical …, 2007 - Springer
Allopurinol is the drug most widely used to lower the blood concentrations of urate and,
therefore, to decrease the number of repeated attacks of gout. Allopurinol is rapidly and …

Tolerability of paracetamol

GG Graham, KF Scott, RO Day - Drug safety, 2005 - Springer
The excellent tolerability of therapeutic doses of paracetamol (acetaminophen) is a major
factor in the very wide use of the drug. The major problem in the use of paracetamol is its …

Allopurinol hypersensitivity: a systematic review of all published cases, 1950–2012

…, MWH Smith, N Wang, DM Roberts, GG Graham… - Drug safety, 2013 - Springer
Background Allopurinol is the primary therapy for the management of chronic gout. Utilization
of allopurinol has increased in tandem with the growing prevalence of gout globally. This …